PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
September 23, 2025ACS Infectious Diseases22 citationsOpen Access

Synergistic Paradigms in Infection Control: A Review on Photodynamic Therapy as an Adjunctive Strategy to Antibiotics

View Full Paper
JSJennifer M. SoaresTCThaila Quatrini CorrêaCPClaudia Patricia Barrera Patiño

Key Points

  • Combining photodynamic therapy and antibiotics improves bacterial treatment outcomes, enhancing efficacy against infections.
  • The review identifies mechanisms such as reactive oxygen species generation that increase antibiotic susceptibility and reduce dosages.
  • A systematic literature search highlighted experimental approaches and challenges in integrating photodynamic therapy into routine clinical practice.
  • Future research aims to refine therapeutic parameters and address obstacles for broader implementation of photodynamic therapy as an adjunct treatment.

Abstract

The increasing threat of antimicrobial resistance necessitates developing novel strategies to enhance the efficacy of existing antibiotics. This review explores the potential of antimicrobial photodynamic therapy (aPDT) as an adjunctive approach to antibiotic therapy. A systematic literature search was conducted in major scientific databases, focusing on studies published in the past decade investigating the synergistic effects of aPDT with antibiotics. Selected articles were analyzed based on their experimental approaches, bacterial targets, photodynamic parameters, and reported treatment outcomes. aPDT induces bacterial cell damage by generating reactive oxygen species (ROS), enhancing antibiotic susceptibility, and reducing required dosages. Furthermore, the review highlights promising research on optimizing treatment parameters and antibiotic combination strategies to maximize therapeutic outcomes. Despite its potential, aPDT faces obstacles to treatment standardization, variability in bacterial responses, and clinical implementation hurdles. These challenges require standardized protocols, further in vivo studies, and regulatory advancements to integrate aPDT into mainstream antimicrobial therapy. Conclusion: The synergy between aPDT and antibiotics represents a promising frontier in infection control, offering a safer, more effective, and resistance-mitigating strategy for bacterial infections. Future research should focus on refining treatment parameters, assessing long-term clinical impacts, and facilitating the widespread adoption of aPDT as a complementary antimicrobial approach.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Soares et al. (2025) studied this question.

synapsesocial.com/papers/68d473b531b076d99fa6c616https://doi.org/10.1021/acsinfecdis.5c00369
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12‐month follow‐up2011 · 45 citations
  2. 2Accelerated evolution of resistance in multidrug environments2008 · 316 citations
  3. 3Biosecurity and water, sanitation, and hygiene (WASH) interventions in animal agricultural settings for reducing infection burden, antibiotic use, and antibiotic resistance: a One Health systematic review2023 · 120 citations
  4. 4Diagnosing oxidative stress in bacteria: not as easy as you might think2015 · 278 citations
  5. 5Molecular mechanisms of antibiotic resistance2014 · 4,058 citations